Regulatory Binder – Document Checklist

Regulatory binders are used to organize and maintain research study documentation including all regulatory documentation, such as ORHP requirements[1], FDA regulations[2] and documentation guidelines for good clinical practice (GCP)[3].  Although study teams at Penn State have the CATS IRB system to track their IRB protocols and documentation related to human subjects research, CATS IRB is not intended to store all regulatory documentation.  Having a regulatory binder can help any researcher meet regulatory requirements and establish a high standard of record-keeping for human subjects research.

A regulatory binder can be physical or electronic copies of the necessary documentation. If keeping electronic copies, organize files within electronic folders for a specific study. Although the regulatory binder is especially beneficial for research subject to regulations beyond the IRB, maintaining a regulatory binder of pertinent IRB information, such as notes to file, study team member training and study procedures applies to all studies.

A binder can help basic science and clinical researchers to

  • Create a longitudinal archive of the study
  • Maintain regulatory compliance
  • Promote transparency
  • Promote accountability
  • Document safety monitoring

[1] 45 CFR 46 at http://ohrp.osophs.dhhs.govwith the standards of Good Clinical Practice and with all applicable regulatory requirements

[2]21 CFR 11, 50, etc. at www.fda.gov

[3] ICH/GCP at www.ich.org

The following is a checklist of documents (all versions) that should be collected and filed in the regulatory binder, if applicable to the clinical study.

SectionRequired Y or N/ADocument
Protocol, Procedures and AmendmentsYes or N/ALog of protocol changes
Protocol, Procedures and AmendmentsYes or N/AInstitutional Review Board (IRB)-approved protocol
Protocol, Procedures and AmendmentsYes or N/AIRB-approved recruitment materials
Protocol, Procedures and AmendmentsYes or N/AStudy Standard Operating Procedures (SOPs)
Informed Consent DocumentsYes or N/ALog of Informed Consent versions
Informed Consent DocumentsYes or N/AIRB-approved Informed Consents*
IRB Approvals and CorrespondenceYes or N/AIRB approval letters (e.g., initial submission, continuing review and modifications)
IRB Approvals and CorrespondenceYes or N/AIRB correspondence (emails/conversations not recorded in CATS IRB)
IRB Approvals and CorrespondenceYes or N/AIRB-approved documents
Study CommunicationYes or N/ALetter of Understanding/Confidentiality Agreement
Study CommunicationYes or N/AData Sharing Agreement
Study CommunicationYes or N/AMaterial Transfer Agreement
Study CommunicationYes or N/ASigned agreements between parties (i.e., sponsors/investigators)
Study CommunicationYes or N/AImportant decisions regarding study conduct, such as notes to the Study File
Study CommunicationYes or N/ANotes to File
Screening/Enrollment LogYes or N/AScreening/Enrollment Log
Screening/Enrollment LogYes or N/AA log without identifying information that lists all screened subjects
Screening/Enrollment LogYes or N/ASubject Identification Code list (which should be kept separately)
Signed Consent Documents (may be kept in a separate binder)Yes or N/AStudy Product Records (documentation of study product and accountability forms/logs)
Serious Adverse Events (SAE)/Unanticipated Problem Documents/Reportable New InformationYes or N/ASAE Report Forms
Serious Adverse Events (SAE)/Unanticipated Problem Documents/Reportable New InformationYes or N/AUnanticipated Problem Forms
Serious Adverse Events (SAE)/Unanticipated Problem Documents/Reportable New InformationYes or N/AIND Safety Reports (if applicable)
Serious Adverse Events (SAE)/Unanticipated Problem Documents/Reportable New InformationYes or N/AReportable New Information (RNI)
Protocol Deviation Form or MemoYes or N/AProtocol Deviation Form or Memo
Data and Safety Monitoring DocumentsYes or N/AData and Safety Monitoring Plan (if not included as part of the study protocol)
Data and Safety Monitoring DocumentsYes or N/AStudy reports generated for Independent Safety Monitor(s)
Data and Safety Monitoring DocumentsYes or N/AMinutes from independent safety monitor(s) meeting(s)
Data and Safety Monitoring DocumentsYes or N/ARecommendations and correspondence from the independent safety monitor(s)
Specimen Tracking Log (if applicable)Yes or N/ASpecimen Tracking Log
Post-IRB Approval Review Reports and Corrective Action/Preventive Action (CAPA) Reports (if applicable)Yes or N/APost-IRB Approval Review (PAR) Reports
Post-IRB Approval Review Reports and Corrective Action/Preventive Action (CAPA) Reports (if applicable)Yes or N/ACorrective Action/Preventive Action (CAPA) Reports
Clinical Site Monitoring Visits (if applicable)Yes or N/ASite visit log
Clinical Site Monitoring Visits (if applicable)Yes or N/ASite visit reports
Clinical Site Monitoring Visits (if applicable)Yes or N/ASite visit correspondence
Laboratory Certification (Clinical Laboratory Improvement Amendments [CLIA], College of American Pathologists [CAP], etc.) (if applicable)Yes or N/AUpdated normal-range values for each reference laboratory
Laboratory Certification (Clinical Laboratory Improvement Amendments [CLIA], College of American Pathologists [CAP], etc.) (if applicable)Yes or N/AA copy of certifications or accreditations (CAP, CLIA, or state certificate)
Sponsor Correspondence (if applicable)Yes or N/ASponsor Correspondence
Financial Disclosure Forms (if applicable)Yes or N/ASigned Financial Disclosure Forms for the PI and co-investigators
FDA Documents (if applicable)Yes or N/AFDA Forms 1571 and 1572
FDA Documents (if applicable)Yes or N/ASample of labels attached to investigational product containers
FDA Documents (if applicable)Yes or N/ARegulatory approval or authorization
FDA Documents (if applicable)Yes or N/AFDA Correspondence Log
Delegation of Authority Log (recommended for Clinical Trial)Yes or N/ADelegation of Authority Log
Clinical Research and Study Training (recommended for Clinical Trial)Yes or N/ADocumentation of human subject protection training and Good Clinical Practice training (for all staff members)
Clinical Research and Study Training (recommended for Clinical Trial)Yes or N/ADocumentation of Dangerous Goods Training (if applicable)
Investigator Qualification Documentation (recommended for Clinical Trial)Yes or N/AUpdated investigator and sub-investigator CVs (signed/dated within 2 years)
Investigator Qualification Documentation (recommended for Clinical Trial)Yes or N/AA clinical (dental, medical, etc.) license for the PI and co-investigators
Clinical Investigator’s Brochure (recommended for Clinical Trial)Yes or N/AClinical investigator’s brochure
Clinical Investigator’s Brochure (recommended for Clinical Trial)Yes or N/APackage insert; include labeling for approved medications
Study Product Records (may be kept in the research pharmacy to protect the blind)Yes or N/ADocumentation of study product (e.g., botanicals, probiotics, or other natural products) disposition and accountability, or memo as to where records are located (e.g., research pharmacy) and who is maintaining accountability logs
Other DocumentsYes or N/AUnmasking procedures for blinded trials
Other DocumentsYes or N/ACertificate(s) of Confidentiality
Other DocumentsYes or N/AOther study documents

*Note: All IRB-watermarked versions of the consent should be kept. The CATS IRB system does not keep these on file once the form is revised.

Office for Research Protections

Address

200 Innovation Blvd.
Suite 110
University Park, PA 16802

The Office for Research Protections (ORP) ensures that research at the University is conducted in accordance with federal, state, and local regulations and guidelines that protect human participants, animals, students, and personnel involved with research.

Contact

Phone: (814) 865-1775

Email: orp@psu.edu